| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/09/2008 | EP1940820A1 Midazole-4-carboxamide derivatives for use as cb modulators |
| 07/09/2008 | EP1940819A1 Phosphodiesterase 10 inhibitors |
| 07/09/2008 | EP1940815A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 07/09/2008 | EP1940807A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 07/09/2008 | EP1940799A1 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 07/09/2008 | EP1940435A2 An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia |
| 07/09/2008 | EP1940415A1 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3 |
| 07/09/2008 | EP1940407A2 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
| 07/09/2008 | EP1940402A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/09/2008 | EP1940399A2 Use of par-i/par- 4 inhibitors for treating or preventing vascular diseases |
| 07/09/2008 | EP1940391A1 Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor |
| 07/09/2008 | EP1940388A2 Dpp iv inhibtor for use in the treatment of autoimmune diseases and graft rejection |
| 07/09/2008 | EP1940378A1 Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases |
| 07/09/2008 | EP1940374A2 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 07/09/2008 | EP1940248A1 Nutritional formulation for promoting catch-up growth |
| 07/09/2008 | EP1789041B1 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 07/09/2008 | EP1660062B1 Use of colipase-lipase inhibitors in the preparation of a pharmaceutical composition in order to prevent obesity |
| 07/09/2008 | EP1653957B1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 07/09/2008 | EP1583762B1 Pyrrolyl-thiazoles and their use as cb 1 receptor inverse agonists |
| 07/09/2008 | EP1539136B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 07/09/2008 | EP1523571B1 Sgk and nedd used as diagnostic and therapeutic targets |
| 07/09/2008 | EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1411780B1 Soluble roasted chicory with high inulin content |
| 07/09/2008 | EP1385499B1 Use of carnitine for the preparation of an injection solution for preventing or alleviating ascites in poultry by in-ovo injection |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP1303304B1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 07/09/2008 | EP1276729B1 New neurokinin antagonists for use as medicaments |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | EP0959878B1 Method for treating renal failure |
| 07/09/2008 | EP0871451B2 Composition comprising plant stanol esters and the use thereof for lowering the serum cholesterol |
| 07/09/2008 | CN101218246A Improved crystalline form of compound A-348441 |
| 07/09/2008 | CN101218236A 2-heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 07/09/2008 | CN101218233A PPARalpha/gamma agonists and processes of preparing |
| 07/09/2008 | CN101218230A Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 07/09/2008 | CN101218220A Choline salt crystal of azulene compound |
| 07/09/2008 | CN101218217A Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof |
| 07/09/2008 | CN101217965A Glucose uptake modulator and method for treating diabetes or diabetic complications |
| 07/09/2008 | CN101217953A Compounds having immunomodulator activity |
| 07/09/2008 | CN101215324A Exenatide short peptide simulation peptide and application thereof in preparing medicament for curing diabetes |
| 07/09/2008 | CN101215297A Statin-diphosphonic acid conjugates, preparation method and application thereof |
| 07/09/2008 | CN101215253A Crystalline forms of atorvastatin |
| 07/09/2008 | CN101214373A Pre-meal insulin dosage control method |
| 07/09/2008 | CN101214352A Chinese medicine for treating hyperlipemia |
| 07/09/2008 | CN101214319A Chinese medicine health care products capable of regulating blood fat and preparation thereof |
| 07/09/2008 | CN101214303A Application of í«damingí» capsule for treating diabetic cardiac disease |
| 07/09/2008 | CN101214279A Method for extracting flavone and polysaccharide from mulberry leaf |
| 07/09/2008 | CN101214271A Blumea balsamifera total flavones dispersible tablet and preparation thereof |
| 07/09/2008 | CN101214269A Method for extracting and concentrating total flavones of ilex hainanensis |
| 07/09/2008 | CN101214263A Method for preparing freeze-dried powder containing bacillus natto and nattokinase |
| 07/09/2008 | CN101214257A Medicinal composition for treating diabetes chronic complication and preparation method thereof |
| 07/09/2008 | CN101214219A Method for preparing vitamin A and vitamin E nano-sphere/microsphere double-embedding system |
| 07/09/2008 | CN101214071A Beauty treatment fat-reducing beverage and its manufacturing method |
| 07/09/2008 | CN101214053A Health-care beverage |
| 07/09/2008 | CN101214049A Health food with auxiliary blood fat reducing function |
| 07/09/2008 | CN101214046A Method for preparing ginkgo biloba oil powder |
| 07/09/2008 | CN100400540C Isoxazoline derivatives as anti-depressants |
| 07/09/2008 | CN100400535C Adiponectin expression promoter |
| 07/09/2008 | CN100400534C Aldose reductase inhibitor, preparation method and use thereof |
| 07/09/2008 | CN100400515C Isoquinoline derivatives and methods of use thereof |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/09/2008 | CN100400512C Benzoic acid derivatives as modulators of PPAR alpha and gamma |
| 07/09/2008 | CN100400504C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/09/2008 | CN100400097C Insulin liquid formulations for nose administration |
| 07/09/2008 | CN100400081C Medicine for treating diabetes and production method thereof |
| 07/09/2008 | CN100400066C Health-care medicine for lowering content of cholesterol and triglyceride in blood |
| 07/09/2008 | CN100400064C Glucoside compound preparation and its preparing process |
| 07/09/2008 | CN100400048C Application of physalis alkekengi polysaccharide in preparation of medicine and health care product for treating diabetes |
| 07/09/2008 | CN100400040C Tripeptidyl peptidase inhibitors |
| 07/09/2008 | CN100399941C Process for producing one or more kinds of dry powder of carotenoid |
| 07/08/2008 | US7396927 Process for preparation of rosuvastatin calcium |
| 07/08/2008 | US7396920 Tumour suppressor and uses thereof |
| 07/08/2008 | US7396858 Biguanide derivative and therapeutic agent for diabetes containing the same |
| 07/08/2008 | US7396850 Pyrazole derivative as PPAR modulator |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396836 Pyrimidine compound and medicinal composition thereof |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396811 Subcellular targeting of therapeutic proteins |
| 07/08/2008 | US7396809 Methods and reagents for treating glucose metabolic disorders |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2481220C Dietary methods for canine performance enhancement |
| 07/08/2008 | CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2422819C Food supplement |
| 07/08/2008 | CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 07/08/2008 | CA2372377C A novel inhibitor of beta amyloid cleavage enzyme |
| 07/08/2008 | CA2328025C Compositions containing fat-soluble vitamins |
| 07/08/2008 | CA2286631C Solid compositions suitable for oral administration comprising l-carnitine or an alkanoyl-l-carnitinecholine tartrate |
| 07/08/2008 | CA2285550C Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate |
| 07/08/2008 | CA2285380C Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-amino-ethanesulfonic acid |
| 07/08/2008 | CA2221455C Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids |
| 07/03/2008 | WO2008080064A1 Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders |
| 07/03/2008 | WO2008079610A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 07/03/2008 | WO2008079398A1 Methods for treating obesity with a combination comprising a mtp inhibitor and a cholesterol absorption inhibitor |
| 07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | WO2008078837A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 07/03/2008 | WO2008078797A1 Sodium absorption inhibitor, potassium absorption inhibitor, phosphorus absorption inhibitor and preventive agent, therapeutic agent and food containing the same |
| 07/03/2008 | WO2008078795A1 Metal salt of crosslinked cellulose derivative |